1478629

Ondansetron Related Compound D

United States Pharmacopeia (USP) Reference Standard

• Sinonimo/i: 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one, 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one
• Formula empirica (notazione di Hill): C₁₄H₁₃NO
• Numero CAS: 99614-64-9
• Peso molecolare: 211.26
• Beilstein: 7920329
• Numero MDL: MFCD08063682
• Codice UNSPSC: 41116107
• ID PubChem: 329750615
• NACRES: NA.24

Proprietà

• Grado: pharmaceutical primary standard
• Famiglia di API: ondansetron
• Produttore/marchio commerciale: USP
• applicazioni: pharmaceutical (small molecule)
• Formato: neat
• Stringa SMILE: Cn1c2CCC(=C)C(=O)c2c3ccccc13
• InChI: 1S/C14H13NO/c1-9-7-8-12-13(14(9)16)10-5-3-4-6-11(10)15(12)2/h3-6H,1,7-8H2,2H3; AGQJDIDJKSFVTC-UHFFFAOYSA-N

Descrizione

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Ondansetron Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:

• Ondansetron Oral Solution
• Ondansetron Injection
• Ondansetron
• Ondansetron Hydrochloride
• Ondansetron Orally Disintegrating Tablets

Risultati analitici

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Altre note

Sales restrictions may apply.